Categories AlphaGraphs, Earnings, Health Care

Trxade Health (MEDS) reports 20% growth in Q4 revenue; results beat estimates

Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company’s revenues increased 20%.

Trxade Q4 2021 earnings infographic

Fourth-quarter revenues increased 19.7% year-over-year to $2.4 million and came in above analysts’ estimates. The company added 175 registered members during the three-month period.

Trxade reported a net loss of $0.8 million or $0.10 per share for the fourth quarter, which marked an improvement from the $2.3 million or $0.29 per share loss reported in the year-ago quarter. The bottom line also beat analysts’ estimates.

Check this space to read management/analysts’ comments on Trxade’s Q4 2021 results

Shares of Trxade closed Monday’s trading higher and continued to gain in the extended session, soon after the earnings announcement. The stock has lost about 55% in the past six months.

Prior Performance

  • Trxade Health Q3 2021 earnings
  • Trxade Health Q2 2021 earnings
  • Trxade Q1 2021 earnings
  • Trxade Q4 2020 earnings

Most Popular

IPO Alert: Here’s what to look for when CaliberCos goes public

The massive slowdown in the IPO market continued in the second half as the challenges posed by high inflation and interest rate hikes weighed on investor confidence. Meanwhile, there is

CarMax (KMX) Stock: Does the current dip offer a buying opportunity?

The automotive sector is one of the worst affected by the combination of high inflation and rising interest rates. Consumers have become more cautious and are prioritizing their purchases with

Ultimax Digital gears up for $10mln IPO. Here’s all you need to know

The IPO market has witnessed muted activity this year, and things don’t seem to have improved in the second half. The upcoming public listing of video game technology firm Ultimax

Add Comment
Viewing Highlight